Scientific Session
Systemic lupus erythematosus (SLE)
Mary Beth Son, MD
Boston Children's Hospital
Brookline, Massachusetts, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Lisa Sammaritano, MD
Hospital for Special Surgery
Scarsdale, New York, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Maria Dall'Era, MD
Director
UCSF
Corte Madera, CA, United States
Disclosure(s): AstraZeneca: Consultant (Ongoing); Aurinia: Consultant (Ongoing); GlaxoSmithKlein: Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Advisor or Review Panel Member (Ongoing)
Anca Askanase, MD, MPH
Director
Columbia University Medical Center
New York, NY, United States
Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); Amgen: Advisor or Review Panel Member (Ongoing); AstraZeneca: Consultant (Ongoing); biogen: Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); Cabaletta: Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Idorsia: Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Terminated); Sanofi: Grant/Research Support (Ongoing); UCB: Grant/Research Support (Ongoing)